Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2018 / Cilt: 23 - Sayı: 1

Investigation of Cytomegalovirus, Epstein-Barr Virus and Adenovirus Infections After Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients

Allojenik Hematopoietik Kök Hücre Transplantasyonu Yapılan Çocuklarda Sitomegalovirüs, Epstein-Barr Virüs ve Adenovirüs İnfeksiyonlarının Araştırılması

Pages
15–24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Early diagnosis by monitoring viral load and initiation of preemptive treatment is important to prevent complications of viral infections in patients after HSCT

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Due to immunosuppressive treatments, viral infections, especially cytomegalovirus (CMV), Epstein-Barr virus (EBV) and adenovirus (ADV) infections, are the main causes of morbidity and mortality in patients receiving hematopoietic stem cell transplantation (HSCT).
📊
Key Findings & Data:Materials and Methods: Between November 2015 and November 2016, 51 patients between the ages of 16 months and 16 years having had HSCT were included into the study.
💡
Conclusion & Impact:Conclusion: Early diagnosis by monitoring viral load and initiation of preemptive treatment is important to prevent complications of viral infections in patients after HSCT
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Due to immunosuppressive treatments, viral infections, especially cytomegalovirus (CMV), Epstein-Barr virus (EBV) and adenovirus (ADV) infections, are the main causes of morbidity and mortality in patients receiving hematopoietic stem cell transplantation (HSCT). The aim of this study was to investigate the incidence of CMV, EBV and ADV infections in pediatric patients who had HSCT. Materials and Methods: Between November 2015 and November 2016, 51 patients between the ages of 16 months and 16 years having had HSCT were included into the study. Forty-six patients received allogeneic and 5 patients autologous HSCT. Quantitative realtime PCR (Anatolia Geneworks, Turkey) test was used to detect CMV, EBV and ADV viral load in blood. Results: Of the 46 patients receiving allogeneic HSCT as a single infection or co-infection, viral load above 1000 copies/mL was found in 26% (12) for CMV, in 26% (12) for EBV and 2.1% (1) for ADV. Twenty (43.4%) allogeneic HSCT recipients was put under preemptive therapy and viremia was cleared in 19. Only 1 (2.1%) patient died due to EBV infection and acute graft versus host disease (GVHD). Conclusion: Early diagnosis by monitoring viral load and initiation of preemptive treatment is important to prevent complications of viral infections in patients after HSCT

Özet

Giriş: Hematopoietik kök hücre transplantasyonu (HKHT) yapılan hastalarda immünsüpresif tedaviye bağlı viral infeksiyonlar özellikle sitomegalovirüs (CMV), Epstein-Barr virüs (EBV) ve adenovirüs (ADV) infeksiyonları morbidite ve mortalitenin başlıca sebebidir. Bu çalışmada, HKHT yapılan çocuk hastalarda CMV, EBV ve ADV infeksiyonlarının insidansının araştırılması amaçlanmıştır. Materyal ve Metod: Çalışmaya Kasım 2015-Kasım 2016 tarihleri arasında HKHT yapılan, yaşları 16 ay ile 16 yıl arasında değişen toplam 51 çocuk hasta dahil edilmiştir. Hastaların 46’sına allojenik, beşine otolog HKHT yapılmıştır. CMV, EBV ve ADV viral yükünün kanda tespiti için kantitatif real-time polimeraz zincir reaksiyonu (PCR) (Anatolia Geneworks, Türkiye) testi kullanılmıştır. Bulgular: Allojenik HKHT yapılan 46 hastada tekli infeksiyon veya koinfeksiyon şeklinde olmak üzere %26 (n= 12)’sında CMV, %26 (n= 12)’sında EBV ve %2.1 (n= 1)’inde ADV viral yükü 1000 kopya/mL’nin üstünde bulunmuştur. Allojenik HKHT alıcısı 20 (%43.4) hastaya preemptif tedavi uygulanmış ve 19’unda viremi temizlenmiştir. Sadece 1 (%2.1) hasta EBV infeksiyonu ve akut graft versus host hastalığı (GVHH) sebebiyle kaybedilmiştir. Sonuç: HKHT yapılan hastalarda viral yük izlenerek erken tanı konulması ve preemptif tedavinin başlanması viral infeksiyonlara bağlı oluşabilecek komplikasyonların önlenmesi için önemlidir

🔖

Cite This Article

KAYA, N. N., KÜPELİ, S., ÖZTÜRK, G., BAYRAM, İ., SAĞDIÇ, D. Ö., SEZGİN, G., KÖKSAL, F., YARKIN, F. (2018). Investigation of Cytomegalovirus, Epstein-Barr Virus and Adenovirus Infections After Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 23 - Sayı: 1, 15–24. https://ajindex.com/articles/224452

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Lin R, Liu Q. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. J Hematol Oncol 2013;17:94. Rowe RG, Guo D, Lee M, Margossian S, London WB, Lehmann L. Cytomegalovirus infection in pediatric hematopoietic stem cell transplantation: risk factors for primary infection and cases of recurrent and late infection at a single center. Biol Blood Marrow Transplant 2016;22:1275-83.
  2. Sousa H, Boutolleau D, Ribeiro J, Teixeira AL, Pinho Vaz C, Campilho F, et al. Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: a five-year retrospective review. Biol Blood Marrow Transplant 2014;20:1958-67.
  3. Blyth E, Withers B, Clancy L, Gottlieb D. CMV-specific immune reconstitution following allogeneic stem cell transplantation. Virulence 2016;7:967-80. Styczynski J, van der Velden W, Fox CP, Engelhard D, de la Camara R, Cordonnier C, et al; Sixth European Conference on Infections in Leukemia, a joint venture of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation (EBMT-IDWP), the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN). Management of Epstein-Barr virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica 2016;101:803-11.
  4. Wu XL, Liu QF. Epstein-Barr virus-associated diseases in allogeneic hematopoietic stem cell transplantation. J Hematol Oncol 2012;5(Suppl 1):A8. Rouce RH, Louis CU, Heslop HE. Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant. Curr Opin Hematol 2014;21:476-81.
  5. Wy Ip W, Qasim W. Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation. Adv Hematol 2013;2013:176418. van Tol MJ, Claas EC, Heemskerk B, Veltrop-Duits LA, de Brouwer CS, van Vreeswijk T, et al. Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity. Bone Marrow Transplant 2005;35(Suppl 1):S73-6. de la Cámara R. CMV in hematopoietic stem cell transplantation. Mediterr J Hematol Infect Dis 2016;8:e2016031. Xuan L, Jiang X, Sun J, Zhang Y, Huang F, Fan Z, et al. Spectrum of Epstein-Barr virus-associ